NCT05665348
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05665348
Title Study Evaluating the Benefit of Adding Ipilimumab to the Combination of Atezolizumab and Bevacizumab in Patients With Hepatocellular Carcinoma Receiving First-line Systemic Therapy (TRIPLET)
Acronym TRIPLET
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Federation Francophone de Cancerologie Digestive
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA

Facility Status City State Zip Country Details
Chu Amiens Picardie Amiens France Details
CHU Angers France Details
Privé LES BONNETTES Arras France Details
Chu Avicienne Bobigny France Details
Privé Bordeaux Nord Bordeaux France Details
Ch Duchenne Boulogne-sur-Mer France Details
Chu Morvan Brest France Details
Centre Hospitalier Cholet France Details
Chu Estaing Clermont-Ferrand France Details
Chu Beaujon Clichy France Details
CH HCC Colmar France Details
Chu Francois Mitterand Dijon France Details
CHD Vendée La Roche-sur-Yon France Details
Chu Dupuytren Limoges France Details
Chu La Croix Rousse Lyon France Details
CAC Paoli Calmettes Marseille France Details
Chu La Timone Marseille France Details
Privé Saint-Joseph Marseille France Details
Chu Saint-Eloi Montpellier France Details
CHU Hôtel Dieu Nantes France Details
Privé CONFLUENT Nantes France Details
Chu L'Archet Nice France Details
Chu La Pitie Salpetriere Paris France Details
Chu Saint Antoine Paris France Details
Privé Saint-Joseph Paris France Details
Centre Hospitalier Pau France Details
CH Saint-Jean Perpignan France Details
Chu Haut Leveque Pessac France Details
Chu Haut-Leveque Pessac France Details
Privé HPCA Plérin France Details
Chu La Miletrie Poitiers France Details
Ch Annecy Genevois Pringy France Details
Centre Hospitalier Quimper France Details
CHU Robert Debré Reims France Details
CAC Eugène Marquis Rennes France Details
Chu Charles Nicolle Rouen France Details
Chu Saint-Etienne Saint-Priest-en-Jarez France Details
Centre Hospitalier St-Malo France Details
Cac Icans Strasbourg France Details
Privé Sainte Anne Strasbourg France Details
Chu Rangueil Toulouse France Details
CHRU Hôpitaux de Tours Tours France Details
Centre Hospitalier Valence France Details
Chu Brabois Vandœuvre-lès-Nancy France Details
CAC Gustave Roussy Villejuif France Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field